FDA Drugs (New Approvals & NDA)Original article
Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - 03/05/2024
Neutral
AI Analysis
Summary
The FDA is conducting a public workshop on March 5, 2024, to discuss complex adaptive, Bayesian, and other novel clinical trial designs as part of its Prescription Drug User Fee Act performance goals.
Importance:2/10
Sentiment:
0.00
FDA WorkshopClinical Trial DesignAdaptive DesignsBayesian MethodsPDUFA
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 28, 2026 6:48 PM